Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982520priorityCriticalpatent/ECSP982520A/en
Publication of ECSP982520ApublicationCriticalpatent/ECSP982520A/en
La presente invención describe una composición farmacéutica que comprende compuesto (I), caracterizado porque la composición comprende de 2 a 12 mg de compuesto (I) en una forma farmacéuticamente aceptable y opcionalmente un vehículo farmacéuticamente aceptable para el mismo, la utilización del tal composición en medicina, un procedimiento para la preparación del tal composición, y una composición intermedia útil en tal procedimiento.The present invention describes a pharmaceutical composition comprising compound (I), characterized in that the composition comprises from 2 to 12 mg of compound (I) in a pharmaceutically acceptable form and optionally a pharmaceutically acceptable carrier therefor, the use of such composition in medicine, a procedure for the preparation of such a composition, and an intermediate composition useful in such a procedure.
Spontaneously dispersible pharmaceutical composition for oral administration comprising n-benzoyl-staurosporine; method to increase levels of bioavailability. (divisional of only 333-00).
LACTAMA COMPOUND (N) - ((S) -2-HIDROXI-3-METHYLBUTIRILE) -1- (L-ALANINIL) - (S) -1-AMINO-3-METHYL-4,5,6,7-TETRAHYDRO -2H-3-BENZAZEPIN-2-ONA, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE FOR THE INHIBITION OF THE B-AMYLOID PEPTIDE RELEASE AND / OR ITS SYNTHESIS THAT USES IT AND ITS USE FOR THE FABR
PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINE) ETHYL-N-METHYL-1H-INDOL-5-METHANE SULPHONAMIDE, RELATIVE PROCEDURE FOR PREPARATION AND USE OF THE SAME IN TREATMENT OF MAMMALS
1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
DERIVATIVE OF NAFTIRIDIN-DIBENZO [A, D] CICLOHEPTENO-10-ACETICO, PHARMACEUTICAL COMPOSITION, AND THE USE OF THAT DERIVATIVE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.
PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATION